ES2155122T3 - Peptidos y pseudopeptidos azacicloalquilalcanoilicos antitromboticos. - Google Patents

Peptidos y pseudopeptidos azacicloalquilalcanoilicos antitromboticos.

Info

Publication number
ES2155122T3
ES2155122T3 ES95900403T ES95900403T ES2155122T3 ES 2155122 T3 ES2155122 T3 ES 2155122T3 ES 95900403 T ES95900403 T ES 95900403T ES 95900403 T ES95900403 T ES 95900403T ES 2155122 T3 ES2155122 T3 ES 2155122T3
Authority
ES
Spain
Prior art keywords
peptides
composition
pseudopeptidos
azacicloalquilalcanoilicos
antitromboticos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95900403T
Other languages
English (en)
Inventor
Scott I Klein
Bruce F Molino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RHONE POULENC RORER PHARMA
Aventis Pharmaceuticals Inc
Original Assignee
RHONE POULENC RORER PHARMA
Rhone Poulenc Rorer Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RHONE POULENC RORER PHARMA, Rhone Poulenc Rorer Pharmaceuticals Inc filed Critical RHONE POULENC RORER PHARMA
Application granted granted Critical
Publication of ES2155122T3 publication Critical patent/ES2155122T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A AZACICLOALQUILALCANOIL PEPTIDOS Y PSEUDOPEPTIDOS QUE INHIBEN LA AGREGACION PLAQUETARIA Y LA FORMACION DE TROMBOS Y SON POR TANTO UTILES EN LA PREVENCION Y EL TRATAMIENTO DE LA TROMBOSIS ASOCIADA CON ESTADOS PATOLOGICOS TALES COMO EL INFARTO DE MIOCARDIO, LA APOPLEJIA, LAS ENFERMEDADES DE LAS ARTERIAS PERIFERICAS Y LA COAGULACION INTRAVASCULAR DISEMINADA, A METODOS PARA LA PREVENCION O EL TRATAMIENTO DE LA TROMBOSIS EN MAMIFEROS QUE NECESITEN ESTA TERAPIA QUE INCLUYEN LA ADMINISTRACION DE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE ESTOS COMPUESTOS, Y A COMPOSICIONES FARMACEUTICAS QUE INCLUYEN ESTOS COMPUESTOS.
ES95900403T 1993-10-15 1994-10-17 Peptidos y pseudopeptidos azacicloalquilalcanoilicos antitromboticos. Expired - Lifetime ES2155122T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13882093A 1993-10-15 1993-10-15

Publications (1)

Publication Number Publication Date
ES2155122T3 true ES2155122T3 (es) 2001-05-01

Family

ID=22483811

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95900403T Expired - Lifetime ES2155122T3 (es) 1993-10-15 1994-10-17 Peptidos y pseudopeptidos azacicloalquilalcanoilicos antitromboticos.

Country Status (27)

Country Link
US (1) US5866685A (es)
EP (1) EP0812205B1 (es)
JP (1) JP3032297B2 (es)
KR (1) KR100304332B1 (es)
CN (1) CN1135717A (es)
AT (1) ATE199727T1 (es)
AU (1) AU703854B2 (es)
BG (1) BG63166B1 (es)
BR (1) BR9407839A (es)
CA (1) CA2174097C (es)
CZ (1) CZ291378B6 (es)
DE (1) DE69426897T2 (es)
DK (1) DK0812205T3 (es)
ES (1) ES2155122T3 (es)
FI (1) FI961634L (es)
GR (1) GR3035581T3 (es)
HU (1) HU222248B1 (es)
NO (1) NO961460L (es)
NZ (1) NZ275948A (es)
PL (1) PL181749B1 (es)
PT (1) PT812205E (es)
RO (1) RO115520B1 (es)
RU (1) RU2134695C1 (es)
SG (1) SG64919A1 (es)
SK (1) SK47796A3 (es)
UA (1) UA44258C2 (es)
WO (1) WO1995010295A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
CN1135717A (zh) * 1993-10-15 1996-11-13 罗纳-布朗克·罗莱尔药物有限公司 抗血栓形成的氮杂环烷基链烷酰肽和假肽
PL331772A1 (en) * 1996-08-21 1999-08-02 Rhone Poulenc Rorer Pharma Stable non-hygroscopic crystalline form of n-[n-n-(4-piperidin-4-yl)-n-ethylglycin] compounds
IL129877A (en) * 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
CA2306823A1 (en) * 1997-10-10 1999-04-22 Aventis Pharmaceuticals Products Inc. Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
EP1155033A1 (en) * 1998-12-30 2001-11-21 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-[n-[n-(piperdin-4-yl)butanoyl)-n-ethylglycyl]-(l)-aspartyl]-ss-cyclohexylalanine amide
WO2001055175A2 (en) * 2000-01-28 2001-08-02 Aventis Pharma Deutschland Gmbh Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
WO2001072297A1 (en) * 2000-03-27 2001-10-04 The Scripps Research Institute Methods for inhibiting angiogenesis and tumor growth
CN101735307B (zh) * 2008-11-18 2012-05-30 北京航空航天大学 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用
AU2013274406B2 (en) * 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
WO1991004746A1 (en) * 1989-09-29 1991-04-18 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptides and pseudopeptides
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
IL99538A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
AU661659B2 (en) * 1991-04-11 1995-08-03 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptide and pseudopeptide derivatives
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
CN1135717A (zh) * 1993-10-15 1996-11-13 罗纳-布朗克·罗莱尔药物有限公司 抗血栓形成的氮杂环烷基链烷酰肽和假肽

Also Published As

Publication number Publication date
DE69426897D1 (de) 2001-04-19
JPH09507213A (ja) 1997-07-22
BR9407839A (pt) 1997-05-13
AU703854B2 (en) 1999-04-01
DE69426897T2 (de) 2001-07-05
HU9600983D0 (en) 1996-06-28
CZ108496A3 (en) 1996-12-11
UA44258C2 (uk) 2002-02-15
BG63166B1 (bg) 2001-05-31
JP3032297B2 (ja) 2000-04-10
FI961634A7 (fi) 1996-05-23
ATE199727T1 (de) 2001-03-15
PL181749B1 (pl) 2001-09-28
EP0812205A1 (en) 1997-12-17
NO961460L (no) 1996-06-17
PL313975A1 (en) 1996-08-05
EP0812205A4 (en) 1999-03-31
US5866685A (en) 1999-02-02
CZ291378B6 (cs) 2003-02-12
GR3035581T3 (en) 2001-06-29
HUT73856A (en) 1996-09-30
CA2174097C (en) 2002-06-04
AU8123794A (en) 1995-05-04
RU2134695C1 (ru) 1999-08-20
CN1135717A (zh) 1996-11-13
NZ275948A (en) 1997-02-24
RO115520B1 (ro) 2000-03-30
SG64919A1 (en) 1999-05-25
PT812205E (pt) 2001-08-30
BG100544A (bg) 1996-11-29
DK0812205T3 (da) 2001-04-17
HU222248B1 (hu) 2003-05-28
SK47796A3 (en) 1997-03-05
EP0812205B1 (en) 2001-03-14
FI961634L (fi) 1996-05-23
WO1995010295A1 (en) 1995-04-20
HK1006225A1 (en) 1999-02-19
KR100304332B1 (ko) 2001-11-26
FI961634A0 (fi) 1996-04-12
NO961460D0 (no) 1996-04-12
CA2174097A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
ES2155122T3 (es) Peptidos y pseudopeptidos azacicloalquilalcanoilicos antitromboticos.
MX9302519A (es) Empleo de inhibidores de activadores de plasminogeno para el tratamiento de inflamaciones y heridas.
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
PT705100E (pt) Guanidinas substituidas terapeuticas
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
ES2095017T3 (es) Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.
ES2170104T3 (es) Inhibidores de la produccion de proteinas de beta-amiloide.
TR199903020T2 (xx) Trombotik bozukluklar�n tedavisi i�in y�ntemler.
MX9306924A (es) Composiciones antitumorales que contienen derivados de taxano.
ES2183937T3 (es) Inhibidores de la adhesion celular.
MX9800348A (es) Inhibidores de adhesion celular.
ES2121791T3 (es) Composicion farmaceutica para el tratamiento o la prevencion de un tumor maligno.
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
MX9304916A (es) Proceso para la manufactura de una espuma de poliuretano, flexible, y producto obtenido mediante el mismo.
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
ES2163795T3 (es) Composicion farmaceutica contra los tumores e infecciones por papilomavirus.
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
AR016504A1 (es) Composicion proteica estabilizada, forma farmaceutica de dosificacion, un metodo para preparar una forma farmaceutica de dosificacion, uso de la composicion proteica en la fabricacion de medicamentos y kit
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
ES2187646T3 (es) Procedimientos para el tratamiento de inflamaciones y composiciones correspondientes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 812205

Country of ref document: ES